Impact of Early Oral Stimulation on Reducing Cardiorespiratory Events and Transition to Oral Feeding in Preterm Infants
NCT ID: NCT01116765
Last Updated: 2023-04-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
53 participants
INTERVENTIONAL
2010-05-01
2023-04-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Prefeeding Oral Stimulation on Feeding Performance in Preterm Infants
NCT01649362
Efficacy of an Oral Stimulation Protocol in Preterm Infants to Shorten the Period Between Enteral and Oral Nutrition
NCT03016767
Effects of the Oral Stimulation Program in Extreme Preterm Infants
NCT03025815
Effects of Oral Stimulation in Preterm Infants
NCT03911674
Initiation of Oral Feeding at 30 Versus 33 Weeks Postmenstrual Age
NCT01787019
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
experimental group
Infants in the experimental group receive an oral stimulation program consisting of stimulation of the oral structures during 10 consecutive days
stimulation of the oral structure
control group
Infant in the control group receive no stimulation only non nutritive sucking during feeding
no stimulation of the oral structure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no stimulation of the oral structure
stimulation of the oral structure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Term of certain child (calculated according to the date of the last rules and\\or a premature obstetric echography).
* Children devoid of neurological pathology making him(it) clinically unstable (echography transfontanellar and\\or intellectual MRI, electroencephalogram normal, either, intraventricular bleeding of rank 1 and 2 of Papile \[40\], or, intellectual abnormalities in the MRI of type(chap) 1 - 4 according to the classification of modified Paneth \[41\]. (Annex X)
* Children devoid of infectious pathology making him(it) clinically unstable (Protein C-reactive lower than 7).
* In case of ebb gastroenteritis - esophageal symptomatic ( RGO): the child will be treated(handled), by oral route, by location + thickening +/-prokinetic +/-inhibitor pumps in proton.
* According to a protocol of service, all the premature babies of less than 32.
Exclusion Criteria
* Child not included at the postnatal age of 33 past(over) LIMITED COMPANIES.
* Child presenting a genic syndrome, an evolutionary neurological disease, a pathology malformative.
* Child presenting a bleeding intraventricular of rank 3-4 \[ 40 \], intellectual abnormalities in the MRI of type(chap) 5 and 6 according to the classification of modified Paneth \[ 41 \], an ulcer-necrotizing entérocolitis.
* Child among whom both relatives(parents) or legal representatives refused that their child participates in the study.
29 Weeks
33 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique Hopitaux De Marseille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
MURIEL BUSUTIL
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique Hopitaux De Marseille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assistance Publique Hopitaux de Marseille
Marseille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2009-27
Identifier Type: OTHER
Identifier Source: secondary_id
2009-A01191-56
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.